Clinical Trial Update: A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of BB-TL1A-VIAL-HLE in healthy adults and Ulcerative Colitis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BB-TL1A-VIAL-HLE

Snippet

Sponsor: Vial Australia Pty Ltd | Conditions: Ulcerative Colitis (UC) | Phase 1 | Status: TERMINATED